Hirotoshi Echizen

3.9k total citations
100 papers, 3.0k citations indexed

About

Hirotoshi Echizen is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Hirotoshi Echizen has authored 100 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 18 papers in Cardiology and Cardiovascular Medicine and 16 papers in Surgery. Recurrent topics in Hirotoshi Echizen's work include Pharmacogenetics and Drug Metabolism (18 papers), Eicosanoids and Hypertension Pharmacology (8 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Hirotoshi Echizen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Eicosanoids and Hypertension Pharmacology (8 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Hirotoshi Echizen collaborates with scholars based in Japan, United States and South Korea. Hirotoshi Echizen's co-authors include Harumi Takahashi, Michel Eichelbaum, Ryuichi Ogawa, Sosuke Kimura, Toshitaka Kashima, Takashi Ishizaki, B. Vogelgesang, G. Wilkinson, Noritsugu Umeda and Curt R. Freed and has published in prestigious journals such as Blood, PLoS ONE and Brain Research.

In The Last Decade

Hirotoshi Echizen

94 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirotoshi Echizen Japan 28 1.2k 550 460 432 387 100 3.0k
Ingolf Meineke Germany 32 1.2k 1.0× 957 1.7× 444 1.0× 473 1.1× 614 1.6× 89 3.6k
Kazuko Nakagawa Japan 32 620 0.5× 521 0.9× 339 0.7× 454 1.1× 216 0.6× 117 2.8k
Ji‐Hong Shon South Korea 27 833 0.7× 501 0.9× 286 0.6× 205 0.5× 318 0.8× 60 1.9k
Yoseph Caraco Israel 27 946 0.8× 337 0.6× 233 0.5× 244 0.6× 264 0.7× 102 2.3k
Kyoung‐Ah Kim South Korea 35 1.0k 0.8× 840 1.5× 448 1.0× 432 1.0× 562 1.5× 122 3.7k
George K. Dresser Canada 28 1.4k 1.2× 1.5k 2.6× 334 0.7× 425 1.0× 584 1.5× 59 3.9k
Hong‐Guang Xie United States 22 863 0.7× 395 0.7× 284 0.6× 224 0.5× 501 1.3× 40 2.3k
Joyce Blaisdell United States 30 2.8k 2.3× 1.6k 2.9× 697 1.5× 537 1.2× 651 1.7× 35 4.4k
C G Regårdh Sweden 28 798 0.7× 776 1.4× 185 0.4× 307 0.7× 468 1.2× 59 2.8k
Hong‐Hao Zhou China 38 1.4k 1.2× 1.3k 2.3× 432 0.9× 545 1.3× 567 1.5× 165 4.7k

Countries citing papers authored by Hirotoshi Echizen

Since Specialization
Citations

This map shows the geographic impact of Hirotoshi Echizen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirotoshi Echizen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirotoshi Echizen more than expected).

Fields of papers citing papers by Hirotoshi Echizen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirotoshi Echizen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirotoshi Echizen. The network helps show where Hirotoshi Echizen may publish in the future.

Co-authorship network of co-authors of Hirotoshi Echizen

This figure shows the co-authorship network connecting the top 25 collaborators of Hirotoshi Echizen. A scholar is included among the top collaborators of Hirotoshi Echizen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirotoshi Echizen. Hirotoshi Echizen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogawa, Ryuichi, et al.. (2021). Concise synthesis of the major metabolite M8 from ticagrelor and simultaneous determination of ticagrelor and M8 by a novel LC/MS method. Journal of Chemical Research. 45(7-8). 716–720. 2 indexed citations
2.
Shiga, Tsuyoshi, et al.. (2020). Serum Digoxin Concentrations and Outcomes in Patients with Heart Failure and Atrial Fibrillation: A Single-Center Observational Study. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 51(2). 57–64. 2 indexed citations
4.
Nakayama, Hirokazu, Masahiro Suzuki, Toshiaki Kato, & Hirotoshi Echizen. (2019). Vancomycin Pharmacokinetics in Patients with Advanced Cancer Near End of Life. European Journal of Drug Metabolism and Pharmacokinetics. 44(6). 837–843. 5 indexed citations
5.
Ishihara, Yoko, et al.. (2018). <b>Possible Drug Interaction between Oxycodone and Erythromycin: A Case Report and Analyses of Spontaneous Reporting Systems of Adverse Drug Reactions </b>. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 49(6). 205–209. 1 indexed citations
7.
Ogawa, Ryuichi & Hirotoshi Echizen. (2010). Drug-Drug Interaction Profiles of Proton Pump Inhibitors. Clinical Pharmacokinetics. 49(8). 509–533. 132 indexed citations
9.
Ogawa, Ryuichi, Ryoji Kishi, Kiyoshi Mihara, et al.. (2006). Population Pharmacokinetic and Pharmacodynamic Analysis of a Class IC Antiarrhythmic, Pilsicainide, in Patients With Cardiac Arrhythmias. The Journal of Clinical Pharmacology. 46(1). 59–68. 3 indexed citations
10.
Echizen, Hirotoshi. (2006). A quest for individualized warfarin therapy. Japanese Journal of Thrombosis and Hemostasis. 17(4). 430–433.
12.
Echizen, Hirotoshi. (2001). . Japanese Journal of Thrombosis and Hemostasis. 12(2). 111–118.
13.
Yoshimoto, Kazuo, et al.. (1999). Effects of Oral Supplementation with Evening Primrose Oil for Six Weeks on Plasma Essential Fatty Acids and Uremic Skin Symptoms in Hemodialysis Patients. ˜The œNephron journals/Nephron journals. 81(2). 151–159. 56 indexed citations
15.
Ishizaki, Takashi, Yukio Horai, Hirotoshi Echizen, et al.. (1991). Pharmacokinetic Profile of a New Nonsteroidal Anti-Inflammatory Agent, CN-100, in Humans. Clinical Drug Investigation. 3(1). 1–7. 1 indexed citations
16.
Echizen, Hirotoshi, Yasuo Ohta, Hiromichi Shirataki, et al.. (1990). Effects of Subchronic Treatment with Natural Human Interferons on Antipyrine Clearance and Liver Function in Patients with Chronic Hepatitis. The Journal of Clinical Pharmacology. 30(6). 562–567. 17 indexed citations
17.
Fukuhara, Shunichi, et al.. (1989). An Interindividual Variability in the Sensitivity of Atrioventricular Node to Diltiazem in Patients with Paroxysmal Supraventricular Tachycardia. The Journal of Clinical Pharmacology. 29(2). 102–106. 4 indexed citations
18.
Echizen, Hirotoshi & Takashi Ishizaki. (1988). Superiority of Disease-Specific over Conventional Formula in Predicting Creatinine Clearance from Serum Creatinine in Patients with Liver Cirrhosis. Therapeutic Drug Monitoring. 10(4). 369–375. 9 indexed citations
19.
Echizen, Hirotoshi & Michel Eichelbaum. (1986). Clinical Pharmacokinetics of Verapamil, Nifedipine and Diltiazem. Clinical Pharmacokinetics. 11(6). 425–449. 160 indexed citations
20.
Suganuma, Toshiyuki, et al.. (1985). Plasma Concentrations of Lidocaine and Its Principal Metabolites during Intermittent Epidural Anesthesia. Anesthesiology. 63(3). 304–310. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026